non glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 * Bariatric Fusion GLP Activation of the GLP-1 receptor

Looking Ahead: Future Developments in Continuous Glucose Monitoring While the Dexcom G7 has already revolutionized diabetes management, the field of continuous glucose monitoring continues to evolve

Congress could change this in the future, and some organizations are working to get it passed

Liraglutide has a t 1/2 of 13 hours and is administered once daily independently of meals

GLP-1 injection and oral tablet medications are used for weight loss, to treat type 2 diabetes, and to reduce the risk of major adverse cardiovascular events

[DOI] [PubMed] [Google Scholar] 92.Umpierrez G, Pasquel FJ, Duggan E, Galindo RJ

Women of childbearing potential should note that Mounjaro is not recommended during pregnancy or breastfeeding, and additional contraceptive methods are advised for 4 weeks after starting treatment and after each dose increase